Influence of several convulsants on the protective activity of a non-competitive AMPA/kainate antagonist, LY 300164, and lamotrigine against maximal electroshock in mice

Journal of Physiology and Pharmacology

Volumn 53, Issue 4 II, 2002, Pages 859-869

  Borowicz, K K ^a   Swiader M ^a   Zgrajka, W ^b   Sawulski, C ^c   Turski, W A ^a,b   Czuczwar, Stanisł ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^c Jan Bozy District Hospital   (Poland)

Author keywords

Aminophylline; Bicuculline; Electroconvulsions; Lamotrigine; LY 300164; Picrotoxin; Strychnine

Indexed keywords

AMINOPHYLLINE; AMPA RECEPTOR ANTAGONIST; BICUCULLINE; LAMOTRIGINE; PICROTOXIN; STRYCHNINE; TALAMPANEL;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVULSION; DRUG BLOOD LEVEL; DRUG DOSE; ELECTRIC SHOCK; GABAERGIC SYSTEM; INHIBITION KINETICS; MALE; MAXIMUM ALLOWABLE CONCENTRATION; MOUSE; NEUROTRANSMISSION; NONHUMAN;

AMINOPHYLLINE; ANIMALS; ANTICONVULSANTS; BENZODIAZEPINES; BICUCULLINE; CONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROSHOCK; GABA ANTAGONISTS; MALE; MICE; PICROTOXIN; PROTECTIVE AGENTS; RECEPTORS, AMPA; STRYCHNINE; TRIAZINES;

EID: 12244270368     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Dingledine R, McBain CJ, McNamara JO. Excitatory amino acid receptors in epilepsy. Trends Pharmacol Sci 1990; 11: 334-338.
2. Czuczwar SJ, Meldrum BS. Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid. Eur J Pharmacol 1982; 232: 59-64.
3. Meldrum B. Is epilepsy a disorder of excitatory transmission? In What is Epilepsy?, MR Trimble, EH Reynolds (eds). Edinburgh, Churchill-Livingstone, 1986, p. 293.
4. Löscher W, Nolting B, Hönack D. Evaluation of CPP, a selective NMDA antagonist in various models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital. Eur J Pharmacol 1988; 152: 9-17.
5. Meldrum BS. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. Clin Sci 1985; 65: 113-122.
6. Czuczwar SJ, Świáder M, Kuźniar H, Gasior M, Kleinrok Z. LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs. Eur J Pharmacol 1998; 359: 103-109.
7. Borowicz KK, Kleinrok Z, Czuczwar SJ. Glutamate receptor antagonists differentially affect the protective activity of conventional antiepileptics against amygdala-kindled seizures in rats. Eur Neuropsychopharmacol 2001; 11: 61-68.
8. Nicolson A, Leach JP. Future prospects for the drug treatment of epilepsy. CNS Drugs 2001; 15: 955-968.
9. Stables JP, Bialer M, Johannessen SI, et al. Progress report on new antiepileptic drugs. A summary of the Second Eilat Conference. Epilepsy Res 1995; 22: 235-246.
10. Löscher W. New visions in the pharmacology of anticonvulsion. Eur J Pharmacol 1998; 342: 1-13.
11. Czuczwar SJ, Turski WA, Ikonomidou C, Turski L. Aminophylline and CGS 8216 reverse the protective action of diazepam against electroconvulsions in mice. Epilepsia 1985; 26: 693-696.
12. Czuczwar SJ, Jäckel R, Löscher W. Effects of aminophylline and enprofylline on the protective activity of phenobarbital against amygdala-kindled seizures in rats. Epilepsy Res 1987; 1: 234-238.
13. Czuczwar SJ, Kleinrok Z, Turski L, Turski WA. Effects of aminophylline and enprofylline on the protective activity of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 1987; 28: 383-386.
14. Dragunov M, Goddard GV, Laverty R. Is adenosine an endogenous anticonvulsant? Epilepsia 1985; 26: 480-487.
15. Pilip S, Urbańska EM, Świa̧der M, et al. Anticonvulsant action of chlormethiazole is prevented by subconvulsive amounts of strychnine and aminophylline but not by bicuculline and picrotoxin. Pol. J Pharmacol 2000; 52: 267-273.
16. Skerrit JH, Davies LP, Johnston GAR. Interactions of the anticonvulsant carbamazepine with adenosine receptors. I. Neurochemical studies. Epilepsia 1983; 24: 634-642.
17. Meldrum BS. Epilepsy and GABA-mediated inhibition. Int Rev Neurobiol 1975; 17: 1-36.
18. Löscher W, Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 1988; 2: 145-181.
19. Czuczwar SJ, Wodarczyk D, Gasior M, Kleinrok Z. Is there a glycinergic component in the mechanisms of action of common antiepileptic drugs? In Physiology, Pharmacology and Development of Epileptogenic Phenomena. MR Klee, HD Lux, EJ Speckmann (eds.) Springer, Berlin, Heidelberg, New York, Tokyo, 1991, pp. 255-257.
20. Litchfield JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949; 96: 99-113.
21. Obara N. Involvement of GABAergic and NMDA systems in drug induced convulsions in mice. Sheng Li Hsueh Pao 1994; 46: 505-508.
22. Czuczwar SJ. Effect of combined treatment with dopaminergic and GABA-ergic drugs on the threshold for maximal electroconvulsions in mice. Pol J Pharmacol 1981; 33: 25-35.
23. Czuczwar SJ, Ikonomidou C, Kleinrok Z, Turski L, Turski, WA. Effect of aminophylline on the protective action of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 1986; 27: 204-208.
24. Czuczwar SJ, Janusz W, Szczepanik B, Wamil A, Kleinrok Z. Effect of aminophylline upon the protective activity of common antiepileptic drugs and their plasma levels in mice. Neurosci Res 1989; 6: 470-474.
25. Borowicz KK, Kozicka M, Kleinrok Z, Czuczwar SJ. Influence of aminophylline and 8-(p-sulfophenyl)theophylline on the anticonvulsive action of diphenylhydantoin, phenobarbital, and valproate against maximal electroshock-induced convulsions in mice. J Neural Transm 1993; 93: 157-163.
26. Czuczwar SJ, Kleinrok Z. Modulation of the protective efficacy of common antiepileptic drugs by xanthine derivatives: Implications for the clinical use of xanthines in epileptic patients. Pharmacol Res 1990; 22: 661-665.
27. Czuczwar SJ, Szczepanik B, Wamil A, Janusz W, Kleinrok Z. Differential effects of agents enhancing purinergic transmission upon the antielelctroshock efficacy of carbamazepine, diphenylhydantoin, diazepam, phenobarbital, and valproate in mice. J Neural Transm 1990; 81: 153-166.
28. Arun P, Ravikumar A, Leelamma S, Kurup PA. Endogenous alkaloids in the brain of rats loaded with tyrosine/tryptophan and in the serum of patients of neurodegenerative and psychiatric disorders. Indian J Med Res 1998; 107: 231-238.
29. Ravikumar A, Arun P, Devi KV, Kurup PA. Endogenous strychnine, nicotine, and morphine - Description of hypo and hyper-strychninergic, nicotinergic and morphinergic state in relation to neuropsychiatric diseases. Indian J Exp Biol 2000; 38: 559-566.
30. Tutka P, Turski WA, Kleinrok Z, Czuczwar SJ. Influence of aminophylline and strychnine on the protective activity of excitatory amino acid antagonists against maximal electroshock-induced convulsions in mice. J Neural Transm 1996; 103: 307-314.
31. Borowicz KK, Gasior M, Kleinrok Z, Czuczwar SJ. The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics. Eur J Pharmacol 1995; 281: 319-326.
32. Gasior M, Świa̧der M, Przybyłko M, et al. Felbamate demonstrates low propensity for interaction with methylxanthines and Ca2+ channel modulators against experimental seizures in mice. Eur J Pharmacol 1998; 352: 207-214.